Generation Bio Co (NASDAQ: GBIO) is -79.30% lower on its value in year-to-date trading and has touched a low of $0.30 and a high of $3.65 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GBIO stock was last observed hovering at around $0.43 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $0.56, the stock is 51.78% and 48.31% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.47 million and changing 32.63% at the moment leaves the stock -41.02% off its SMA200. GBIO registered -46.70% loss for a year compared to 6-month loss of -38.59%. The firm has a 50-day simple moving average (SMA 50) of $0.37866 and a 200-day simple moving average (SMA200) of $0.978935.
The stock witnessed a 53.08% gain in the last 1 month and extending the period to 3 months gives it a 51.07%, and is 49.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.49% over the week and 10.18% over the month.
Generation Bio Co (GBIO) has around 115 employees, a market worth around $37.88M and $24.56M in sales. Profit margin for the company is -292.92%. Distance from 52-week low is 88.08% and -84.52% from its 52-week high. The company has generated returns on investments over the last 12 months (-47.49%).
with sales reaching $2.51M over the same period.The EPS is expected to grow by 45.62% this year, but quarterly earnings will post -24.90% year-over-year. Quarterly sales are estimated to shrink -38.62% in year-over-year returns.
119.0 institutions hold shares in Generation Bio Co (GBIO), with institutional investors hold 84.51% of the company’s shares. The shares outstanding are 67.01M, and float is at 45.82M with Short Float at 1.67%. Institutions hold 72.37% of the Float.
The top institutional shareholder in the company is PRICE T ROWE ASSOCIATES INC /MD/ with over 9.51 million shares valued at $26.83 million. The investor’s holdings represent 14.3205 of the GBIO Shares outstanding. As of 2024-06-30, the second largest holder is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with 8.28 million shares valued at $23.35 million to account for 12.4628 of the shares outstanding. The other top investors are FMR LLC which holds 5.3 million shares representing 7.9848 and valued at over $14.96 million, while BELLEVUE GROUP AG holds 5.8989 of the shares totaling 3.92 million with a market value of $11.05 million.
Generation Bio Co (GBIO) Insider Activity
The most recent transaction is an insider purchase by Quinn Anthony G., the company’s Director. SEC filings show that Quinn Anthony G. bought 125,791 shares of the company’s common stock on Jan 10 ’25 at a price of $0.96 per share for a total of $0.12 million. Following the purchase, the insider now owns 0.21 million shares.
Generation Bio Co disclosed in a document filed with the SEC on Jan 13 ’25 that Quinn Anthony G. (Director) bought a total of 85,000 shares of the company’s common stock. The trade occurred on Jan 13 ’25 and was made at $0.97 per share for $82450.0. Following the transaction, the insider now directly holds 0.3 million shares of the GBIO stock.
